Covid-19 pandemic: Chile capital locks down despite mass vaccination | BBC News:
June 11, 2021 - "Chile has announced a lockdown in the capital Santiago amid rising Covid cases, despite nearly 60% of the country being fully vaccinated. More than eight million residents living in and around the capital now must stay at home from Saturday.
"On Thursday, Chile reported 7,716 new daily cases, with the vast majority of infections being among those who had not been fully vaccinated. Intensive care beds are nearing full capacity, health officials warn. Jose Luis Espinoza, the president of Chile's National Federation of Nursing Association, says his members are 'on the verge of collapse', Reuters reports.
"About 58% of the country's 17.5 million people have been fully vaccinated, and as many as 75% have received at least one vaccine dose.
"But critics have accused the government of getting caught up in triumphalism over the vaccine rollout and of having loosened coronavirus restrictions too fast. Chile's borders had been closed from March to November 2020. But after a strict lockdown had driven infections down, the decision was taken to reopen them.
"Chileans were also given special holiday permits to travel more freely around the country during the southern hemisphere summer holidays. Restaurants, shops, and holiday resorts were opened up to kickstart the faltering economy.
"Chile has had nearly 1.5 million infections since the pandemic began, with more than 30,000 Covid-related deaths, according to America's Johns Hopkins university."
Read more: https://www.bbc.com/news/world-latin-america-57436861
Update: British Medical Journal, April 20, 2021:
""A study published by researchers at the University of Chile on 6 April, in which Cortés was not involved, found that the CoronaVac vaccine was 56.5% effective in preventing infections two weeks after a second dose but only 3% effective after a single dose.... Some 93% of the doses administered [in Chile - gd] were the CoronaVac vaccine, manufactured by Chinese state run pharmaceutical Sinovac, and 7% the more effective Pfizer BioNTech vaccine. Chile’s CoronaVac study results are comparable to previous CoronaVac trials elsewhere and 'were not a surprise,' said Cortés."
No comments:
Post a Comment